Skip to main content

Table 3 Aminoglycoside resistance gene profiles of the GNB in Iran

From: Evaluation of phenotypic and genotypic patterns of aminoglycoside resistance in the Gram-negative bacteria isolates collected from pediatric and general hospitals

AME genes Acinetobacter spp. (327)
N (%)
E. coli (144)
N (%)
K. pneumoniae (140)
N (%)
P. aeruginosa (136)
N (%)
Enterobacter spp. (89)
N (%)
aac (6')-Ib + aph (3')-Ia + aadA15 + aph (3')-II + aph (3')-VIe (n = 14) 1/140 (0.7%) 8/136 (5.9%) 5/89 (5.6%)
aac (6')-Ib + aph (6) + aadA15 + aph (3')-II + aph (3')-Ia (n = 1) 1/144 (0.7%)
aac (6')-Ib + aph (3')-Ia + aadA15 + aph (3')-VIe (n = 52) 27/327 (8.2%) 5/144 (3.5%) 7/140 (5%) 3/136 (2.2%) 10/89 (11.2%)
aac (6')-Ib + aph (3')-Ia + aph (3')-II + aph (3')-VIe (n = 41) 9/327 (2.7%) 1/144 (0.7%) 7/140 (5%) 2/136 (1.5%) 22/89 (24.7%)
aph (3')-Ia + aph (3')-II + aac (6')-Ib + aph (6) (n = 29) 4/327 (1.2%) 1/144 (0.7%) 2/140 (1.4%) 22/89 (24.7%)
aac (6')-Ib + aadA15 + aph (3')-Ia + aph (6) (n = 6) 6/144 (4.2%)
aac (6')-Ib + aph (6) + aadA15 + aph (3')-VIe (n = 3) 3/144 (2%)
aac (6')-Ib + aph (3')-VIe (n = 57) 11/327 (3.4%) 10/144 (6.9%) 19/140 (13.6%) 11/136 (8%) 6/89 (6.7%)
aadA15 + aac (6')-Ib + aph (3')-VIe (n = 66) 24 (7.3%) 11/144 (7.6%) 25/140 (17.8%) 5/136 (3.7%) 1 (1.1%)
aph (3')-Ia + aadA15 + aac (6')-Ib (n = 25) 10/327 (3%) 7/144 (4.9%) 7/140 (5%) 1/89 (1.1%)
aac (6')-Ib + aph (6) + aph (3')-VIe (n = 12) 6/327 (1.8%) 5/136 (3.7%) 1/89 (1.1%)
aac (6')-Ib + aph (6) + aph (3')-II (n = 1) 1/327 (0.3%)
aac (6')-Ib + aadA15 (n = 37) 4/327 (1.2%) 14/144 (9.7%) 15/140 (10.7%) 2/136 (1.5%) 2/89 (2.2)
aph (3')-Ia + aadA15 (n = 15) 9/327 (2.7%) 4/144 (2.8%) 1/140 (0.7%) 1/89 (1.1%)
aac (6')-Ib + aph (6) (n = 3) 3/144 (2%)